发酵大豆 (FSB) 补充剂对胃食道逆流性疾病 (GERD) 的影响
Eugenie Sin Sing Tan1, Rahela Zaman1, Muhammad Akbar Memon2
1Faculty of Medicine and Health Science, UCSI University, Kuala Lumpur 56000, Malaysia.
Nutrients
|August 29, 2024
概括
发酵大豆 (FSB) 补充剂显著降低了胃食道逆流症 (GERD) 的症状和炎症. 这项研究突出了FSB的重点.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 胃食道逆流性疾病 (GERD) 是一种常见的慢性疾病,影响一般医疗实践.
- 关于发酵大豆 (FSB) 用于治疗GERD的研究正在出现,关于最佳剂量和持续时间的数据有限.
- 现有的研究往往缺乏严格性来区分安慰剂效应和真正的益处.
研究的目的:
- 调查发酵大豆 (FSB) 补充剂在管理GERD症状中的有效性.
- 通过测量关键炎症标志物来评估FSB的抗炎作用.
- 评估FSB对GERD患者生活质量的影响.
主要方法:
- 一项为期12周的研究涉及110名参与者 (NCT06524271),每天接受1g的FSB.
- 使用反流性疾病问卷 (RDQ) 评估了GERD症状.
- 测量了炎症标志物 (IL-4,IL-6,IL-8) 和反流和消化不良 (QOLRAD) 的生活质量得分.
主要成果:
- 补充FSB显著降低了胃烧和吐症状 (p <0.05).
- 观察到炎症标志物 (IL-4,IL-6,IL-8) 的显著降低,表明抗炎作用.
- 科拉德评分显著改善,特别是在活力,情绪困扰和身体/社会功能方面 (p < 0.05).
结论:
- 补充FSB在缓解GERD症状方面显示出显著的好处.
- FSB表现出与GERD管理相关的显著抗炎性质.
- FSB改善了患有GERD的患者的整体生活质量,支持其作为辅助疗法的使用.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
296
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
296
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
225
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
225
Barrett Esophagus-II: Clinical Manifestations and Management
127
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
127
Other Disorders of Digestive System
739
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
739
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78


